Holy Grail develops energy storage and battery technology that uses electrons to capture carbon dioxide from the atmosphere. It leverages AI and is involved in the research, development, and engineering of various products like batteries, catalysts, and materials datasets which can be used to cross-validate predictions and simulations of experimental data, enabling industrial clients to ensure and benefit from energy efficiency and economy.

Dunia Innovation is a creating the world's first self-driving laboratory for electrocatalytic CO2 utilization, which will drastically accelerate catalyst research.

Coming soon

To help hospitals reduce preventable errors and cut down costs in litigation, Scalpel Ltd. is building an end to end patient safety platform. This AI-powered platform checks and verifies the implementation of safety steps during surgery using a combination of computer vision and machine learning technologies. Unlike standard checklists, Scalpel’s solution doesn’t require any human interaction. Sitting in the background in an operating room it automatically monitors the process and provides real-time feedback to detect and prevent errors.

Cytera CellWorks, a biotechnology platform, builds machines that automate growing mammalian cells for biotech. Based in London, England, the company was founded by Ignacio Willats and Ali Afshar.

The Engineering Company aims to trigger the next industrial revolution by building technology that radically accelerates the invention process. The platform allows enables the design industrial hardware on a profoundly deeper complex level in a tenth of the speed. The company intends their platform to power the next 100 years of hardware invention.

We are reinventing carbon for a thriving planet. Since 2020, we've rapidly pioneered versatile Direct Air Capture (DAC) technology to remove historic CO₂ emissions from the atmosphere — anywhere, at any scale. Supported by Breakthrough Energy Ventures, the XPRIZE Foundation, Stripe, and the UK government, we've moved a brand new climate technology from lab to live commercial plant in under three years to rapidly empower carbon removal and utilisation pathways.

Parallel Carbon is creating the hardware platform required for a post-fossil-fuel society. To eliminate emissions, they are developing technology that removes carbon dioxide from the atmosphere while producing hydrogen. Their mission is to provide the most scalable solution to climate change.

WHO has defined noise pollution as a silent killer affecting the health of millions of people living in busy cities. Airports are spending millions of euros to compensate for the noise levels caused by low-flying planes. 80% of this noise enters your house through windows which are ineffective in stopping the low-frequency sound. DeNoize has developed an active noise cancellation tech to solve this problem. Our technology converts your windows into an active speaker which cancels the outdoor noise by superimposing an anti-phase signal in real time. Our technology is proven to achieve 95% reduction in the amplitude of transmitted noise, resulting in complete silence inside your homes and offices.

Concr combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment. This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine. Concr aims to: • Reduce treatment resistance • Cut the cost of cancer treatment • Enable proactive treatment adaptation • Save lives

Supercritical produces hydrogen and oxygen with the help of an electrolyzer and works towards creating a zero-carbon future.

on a mission to eliminate solid tumours

Thermulon has developed the first building insulation material to satisfy the criteria of fire-safety, performance and price. Designed from the molecular level up, Thermulon deploys the latest advances in chemical and processing technology into an insulation product that enables buildings to be energy efficient without compromising on fire safety.

Beta Bugs is an insect genetics company that develops and distributes high-performance Black Soldier Fly breeds to insect farmers. The Company's long-term mission is to increase the productivity of our sector, enabling insect protein to compete on price point with existing feed ingredients such as fishmeal and soymeal. In order to deliver this mission, Beta Bugs operates a breeding programme to develop high-performance Black Soldier Fly: HiPer-Fly®, and a Black Soldier Fly egg production site: The Multiplier®, where it produces and supplies its breeds to the UK and international markets. Headquartered at Easter Bush Campus, centre of excellence for animal genetics, where it is has built a long-term collaboration with the Roslin Institute, creators of Dolly the Sheep and leaders in animal genetics.

Aquanzo is a marine protein farming company that challenges the exploitation of the ocean to produce marine ingredients for the aquaculture industry. This is achievable by farming Zooplankton, the natural super ingredient, industrially on land. Aquanzo’s mission is to domesticate and farm Artemia as a feed, at low environmental footprint, for optimal fish and shrimp nutrition. Leveraging agricultural by products and state of the art technologies we produce a high value marine protein source, and help make the aquaculture industry more sustainable. We’ll be producing our first products this year to test with potential partners before scaling to industrial pilot scale. Please get in touch for info on partnership, investment or just to chat about our approach to produce marine proteins without harming the Ocean.

ImmTune Therapies is an operator of a cell therapy process intended to cut out complicated biomanufacturing processes. The company's platform brings cell therapies to many, enabling patients to enjoy a reduction in the costs of treatment, which were previously a burden on patients.

Antiverse is a new type of antibody discovery company accelerating drug development. Its platform exists at the intersection of structural biology, machine learning, and medicine to enable breakthroughs to happen more quickly and cost-effectively. It is dedicated to engineering the future of drug development to change the course of people's lives.

Ancilia develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. Our approach harnesses the natural function of CRISPR to enhance bacterial immunity against viruses and effectively modulate the human microbiome.

Enedra Therapeutics is harnessing the power of synthetic lethality and advanced computational Systems Biology to create therapeutics that work against the complexity, biological and mutational heterogeneity of cancer.

Materialize.X employs chemistry and data science to develop environmentally friendly adhesives and improve manufacturing processes. In the engineered wood industry, they find a scalable non-toxic adhesive to replace the current harmful adhesive, urea-formaldehyde adhesive. In order to improve the effectiveness of the manufacturing process, they create machine-learning optimization algorithms.